DoW Epilepsy Leveraging Research Award

About this funding opportunity

Summary: The intent of the fiscal year 2026 (FY26) Epilepsy Research Program (ERP) Leveraging Research Award is to support basic, translational and/or clinical research that repurposes or expands existing research resources to accelerate the understanding of post-traumatic epilepsy (PTE) and associated comorbidities.

Distinctive Features:

The study must adapt an existing cohort, resource, research tool, or intervention for which PTE was not a prior focus or application.

NEW for FY26 An investigator may be named on only one FY26 ERP Leveraging Research Award application as a Principal Investigator.

Topic areas: General and Cross-cutting R&D, Life Sciences and Health.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are due Aug 17, 2026. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• Open to all applicant types

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

DoW Epilepsy Leveraging Research Award is administered by Defense Health Agency Contracting Activity - DHACA (AMRAA), listed via Grants.gov.